Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,724,724 papers from all fields of science
Search
Sign In
Create Free Account
pyronaridine phosphate salt
Known as:
phenol, 4-((7-chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)-2,6-bis(1-pyrrolidinylmethyl)-, phosphate (1:4)
, pyronaridine tetraphosphate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
pyronaridine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Closing the empty anti-Babesia gibsoni drug pipeline in vitro using fluorescence-based high throughput screening assay.
M. Rizk
,
S. Ji
,
+6 authors
I. Igarashi
Parasitology international
2020
Corpus ID: 210167318
2017
2017
ASSESSMENT OF SAFETY PARAMETERS FOLLOWING REPEATED ARTEMISIN-BASED TREATMENTS OF MALARIA-INFECTED PATIENT LIVING IN ENDEMIC AREA OF BURKINA FASO
S. Coulibaly
,
I. Soulama
,
+12 authors
S. Sirima
BMJ Global Health
2017
Corpus ID: 78833836
Background Artemisinin-based combination therapies (ACTs) constitute the worldwide recommended antimalarial drug as first-line…
Expand
2010
2010
Absorption, Distribution, Excretion, and Pharmacokinetics of 14C-Pyronaridine Tetraphosphate in Male and Female Sprague-Dawley Rats
S. H. Park
,
K. Pradeep
Journal of Biomedicine and Biotechnology
2010
Corpus ID: 19008732
The main objective of this investigation was to determine the absorption, distribution, excretion, and pharmacokinetics of the…
Expand
1999
1999
REPORT : EFFECTS OF PYRONARIDINE ON GAMETOCYTES IN PATIENTS WITH ACUTE UNCOMPLICATED FALCIPARUM MALARIA
P. Ringwald
,
Fleurette Solange Meche
1999
Corpus ID: 85523716
The effects of pyronaridine and chloroquine on mature Plasmodium falciparum gametocytes were compared in 161 patients treated…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE